Member Info for Aldebaran

Ade correct. Going to take a huge effort to turn this around it will be time consuming and expensive and I believe highly dilutive to shareholders. So much so that if this does turn around long term holders still might make zero. Got to get the timing right with these as a lot can go wrong.

2027 will be a good time to analyse and see if management's turnaround plan is working. Currently its nowhere near commercial. Afc are paying speedy AND there customers to try capture market share in advance which is good for anyone buying in 2027 or after but now your cash is being spent. Fast

Technically wouldn't be surprised if we saw a pullback to around 64p. Though up moves have been on high volume and pullbacks and lower volume so far in this newly established uptrend.

It's getting difficult to trade now tbh. So much news due and back to back conferences starting next week were ceo as made clear significant announcements expected so to cell and try buy back 10% cheaper is now more risky as could get caught offside with news. I am holding firm at present

The volume here is insane, it's only been higher than this twice since the turn of the year and that was when RH came on bored and sorted the CLN.

Somethings up. I doubt this volume is retail

Huge volume but no move = buyers and sellers balanced. It'll be those who took part in the 10p placing bailing out knowing another placing is inevitable and they can buy cheaper IMO. They've already been flipping for 10% or so ever since they had the shares. Its what they do.

Compare this to the enormous volume at avacta and upwards trajectory of the share price its chalk. And its. Cheese. I have been trying to explain to you guys avacta is moving rapidly and will be 100p next week.

This isnt moving in a sustainable way until 2027

15 or 30min chart are telling. Up on high volume, pulling back on low volume. Chart is in clear uptrend now with higher highs and lower lows. Pullback being brought up. Expecting 80p this week and 100p next and then what happens around ESMO and AACR could be the beginning of something huge here

Your right mcaquares.

I am bearish on boom but tbh I haven't posted here for ages as just decided to leave you all to it however some weirdo called bearhuntr is following me around these boards just slating any stock im in hence im here returning the favour and id be much more worried being in this than in avacta or hemo so people who live in glass houses shouldn't throw stones.

Sorry to here about your health wish you a full recovery if possible

Wow the volume at avacta particularly is insatiable. Almost 2m traded in first 30mins.

Do people think the profits from the recent pump here are shifting to Avacta? What do you think beerhuntr? I realise you thought 61.5p was the peak then 70p, what is your latest estimate based of your extensive research we are all so desperate over there to hear your latest analysis!

🤡 🤣

Notice how price gapped down as well today, definitely time to take some profits and some risk of the table before the inevitable collapse here which on the back of retail over excitement is inevitable.

Notice how avacta and hemo are both up today also on good news Beerhuntr. Both curing cancer and doing remarkable things. You stick to your little podcasts and waifer thing margins and leave us big boys to make the money from now on hun. You clearly have no idea what you're doing 🤡🤣

Its so obvious what as happened here. I wonder when beerhuntr will realise hes been had and instead of following me around like a bad smell trying to slate good quality companies in there fight against cancer, will he just focus on his own investments. 🤡

I wanted the money to take the wife out so closed it out.

This has got P&D all over it. So what if there was a article out lol.

Anyone can start a podcast company there is such a low barrier to entry. I do not see boom having any USP. it isnt generating free cash flow it had waifer thin margins and operating in a crowded sector. Its valued at over 100m lol

Peak hype if u ask me. Let's remember how takeover talks went last time leading to the almighty dump. Don't be left holding the baby while long term holders like beerhuntr ramp to you for there exit is what I would say this is grossly overvalued and will end in tears.

Meanwhile beerhuntr was saying avacta peaked at 61.5p. He said he was shorting it. He then said it peaked at 70p. Got a feeling he'll be saying its peaked at 80p this week and 100p next lol

What a 🤡

Great but we already had clearance from the FDA ?

AACR is first. 22nd from memory. ESMO is at the end of the month.

Honest Zak haha hes a known enabler to pump and dumps.

Honestly this share is way overhyped for what it is.

Crowded market with such a low barrier to entry, absolutely zero USP and waifer thin margins at best. You can talk about ADJUSTED Ebitda until the cows come home lol

I shorted this recently and took a small profit. Definitely considering same again for next week. Its a strong avoid for me.

Is 28 days up yet CN? You desperate ramper you 😉

Fact is, other stocks are moving and moving rapidly now. A new biotech bull market has started. Much like the hydrogen hype a few years back. There is one heck of a major opportunity at Avacta RIGHT NOW. Not next year, not in 2027 but NOW.

How many wished they listened to me last month? Be honest. You'll be kicking yourself even harder next month as Avacta continues to climb. Im telling you now, spend an hour and do some basic research. For the love of God help yourselves guys!!!!

CC as always been real with us as evidence by that post. Now listen to what she's saying. Total change of tone. Those long awaited deal S... are imminent and will give us the funds and validation we require. Every faith in her to deliver

Quarter 2 NEXT YEAR !!!

OMG what happens between now and then because company have already earmarked all the money from the last placing and if nothing material until then to put this on an upwards trajectory then it'll be the 5p raise ive been predicting. It kind of makes sense for that to be true.

5p placing.

Something material announced mid 2026

That material thing starts to be reflected in the accounts from 2027.

2027 will be the optimal time to buy AFC Energy IMO.

In the meantime ive been telling you guys to look at Avacta since 40ish pence last month, its now at 70p and will hit 80p next week. I know some of you have listened and made a few quid their. Great. Others are a bit slow to cotton on but hopefully you get the message loud and clear now.

Nothing happening here till 2027. Go make money on stocks that are going up in the meantime them plough your profits back in here at a cheaper price!!!!

Its not hard guys ffs.

I think II investment is most likely here. It was said that getting rid of diagnostics unlocked II investment. Same as Peometheus they did the same thing lost there diagnostics business then got 3rd party validation for there therapeutic side and onboarded II's.

There are multiple ways to cut this and dont forget David Bryant and HCRx in addition to multiple partnering discussions for multiple indications across the pipeline. Just so many options available to us right now with 4yrs of data to back it up

I'll take this one Christopher.

The reason the share price has fallen is because it rose so rapidly in a short space of time and not everyone wants to buy and hold forever. It's natural profit taking in the absence of any news or even visibility of news from HEMO in the near future. A lot of hype was put around the conferences in DC & NYC with the usual ramp brigade here claiming big pharma and congress people would be forming disorderly queues to throw money at Vlad.

All we got was a non binding letter of intent for Estonia though.

In terms of guaranteeing you'll make a fortune in 6 months. Nobody can guarantee that. It is likely though IF the trial continues to go well and there are no delays.

Remember this week the World Health Organisation reviewed and validated AVA6000 chemical identity also.

1 million patience per year treatable with Avacta's first two drugs with each treatment costing north of £100k and our drugs being 10x cheaper to manufacture than ADC's make for telephone number calculations when plugging in potential profits.

Ultimately it all boils down to this.

Avactas drugs are silent in the bloodstream and active in the tumour. The holy grail in cancer treatment. Put a price on that

Excellent close today on strong volume going into what is promised to be a news rich period for Avacta. First commercial deal imminent and when fundamentals and technicals line up that's a great sign.

I expect from a technical POV alone we hit 80p next week and peel hunts target of 99p by end of the month. Then things get interesting, if Avactas tech does get validated by a third party deal then where do we get too. I would say around £1bn valuation on a risk adjusted basis is about right pending the P1b read out for salivary gland cancer which has already doubled the progression free survival rates for heavily prentreated patience.

Staggering potential for a huge re-rate here over the next few weeks and months and a myriad of news inbound.